Aging with drug use: Theorizing intersectionally with material gerontology and critical drug studies

被引:4
|
作者
Sultan, Aysel [1 ,2 ]
机构
[1] Frankfurt Univ Appl Sci, Inst Addict Res, Frankfurt, Germany
[2] Goethe Univ, Dept Educ Sci, Frankfurt, Germany
关键词
Aging; Critical drug studies; Habitual drug use; Intersectionality; Material gerontology; Older adults; OLDER-PEOPLE; LATER LIFE; ADDICTION; TRENDS; ADULTS; AGE; REALITIES; ILLICIT; OPIOIDS; MATTER;
D O I
10.1016/j.jaging.2021.100990
中图分类号
R4 [临床医学]; R592 [老年病学];
学科分类号
1002 ; 100203 ; 100602 ;
摘要
Rethinking old age and what aging means within the context and materiality of drug use, this paper asks, 'how does drug use matter in old age?' and follows a series of conceptual arguments to link aging studies and critical drug studies with material gerontology in an intersectional analysis. To do this, four research areas are reviewed to conceptualize habitual drug use in old age. First, aging is explored through its biological, subjective, and sociomaterial representations. Secondly, the merits of material gerontological thinking are discussed and developed in connection to marginalization and related intersectionality representing the third and fourth areas of research, respectively. Conceptual results suggest a model of 'embodied-drugged-aging,' an integrated conceptual approach which neither categorizes nor abstracts aging with drug use from its social and material contexts.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] AGING AND HEAVY DRUG-USE - A PRESCRIPTION SURVEY IN MANITOBA
    AOKI, FY
    HILDAHL, VK
    LARGE, GW
    MITENKO, PA
    SITAR, DS
    JOURNAL OF CHRONIC DISEASES, 1983, 36 (01): : 75 - 84
  • [32] Projecting drug use among aging baby boomers in 2020
    Colliver, JD
    Compton, WM
    Gfroerer, JC
    Condon, T
    ANNALS OF EPIDEMIOLOGY, 2006, 16 (04) : 257 - 265
  • [33] "A more accurate understanding of drug use": A critical analysis of wastewater analysis technology for drug policy
    Lancaster, Kari
    Ritter, Alison
    Valentine, Kylie
    Rhodes, Tim
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 63 : 47 - 55
  • [34] Best Practices for the Use of Itraconazole as a Replacement for Ketoconazole in Drug-Drug Interaction Studies
    Liu, Lichuan
    Bello, Akintunde
    Dresser, Mark J.
    Heald, Donald
    Komjathy, Steven Ferenc
    O'Mara, Edward
    Rogge, Mark
    Stoch, S. Aubrey
    Robertson, Sarah M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (02): : 143 - 151
  • [35] A Case to Support the Continued Use of Rifampin in Clinical Drug-Drug Interaction Studies
    Bercu, Joel P.
    Ponting, David J.
    Ripp, Sharon L.
    Dobo, Krista L.
    Totah, Rheem A.
    Bolleddula, Jayaprakasam
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (01) : 34 - 37
  • [36] Methodological Considerations on the Use of Cohort Designs in Drug-Drug Interaction Studies in Pharmacoepidemiology
    Dimakos, Jenny
    Douros, Antonios
    CURRENT EPIDEMIOLOGY REPORTS, 2024, 11 (03) : 175 - 183
  • [37] Studies on the Stability of Salvianolic Acid B as Potential Drug Material
    Zhou, Li-Na
    Zhang, Xin
    Xu, Wei-Zhuo
    Ma, Xiao-Nan
    Jia, Zhen
    Zheng, Ya-Ming
    You, Song
    PHYTOCHEMICAL ANALYSIS, 2011, 22 (04) : 378 - 384
  • [38] Colonic drug delivery: An investigation into the use of starch as a coating material
    Freire, C.
    Podczeck, F.
    Sousa, J.
    Veiga, F.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 : A27 - A27
  • [39] Assessing the Credibility of Causal Effects: A Critical Analysis of Observational Studies on Pregnancy Drug Use and Congenital Malformations
    Tan, Jing
    Jia, Yulong
    Wang, Jing
    Liu, Chunrong
    Zhao, Peng
    Ren, Yan
    Xiong, Yiquan
    Li, GuoWei
    Sun, Xin
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 446 - 447